A B S T R A C T Patients with active systemic lupus erythematosus (SLE) had a decrease in a subpopulation of cells (fraction D) when peripheral blood lymphocytes were separated on a discontinuous Ficoll gradient. Preincubation of SLE cells at 370C for 30 min led to a marked decrease in this fraction, composed primarily of thymus-derived (T) cells. Supernates of such preincubations were found to cause a reduction in fraction D cells from normal humans. The active factor in the supernate was found to be an IgG antibody. Similarly, serum from patients with active SLE produced a reduction in fraction D cells from normal donors. This activity was also found in the IgG fraction, and could be absorbed with a pure T-cell population.
A B S T R A C T Patients with active systemic lupus erythematosus (SLE) had a decrease in a subpopulation of cells (fraction D) when peripheral blood lymphocytes were separated on a discontinuous Ficoll gradient. Preincubation of SLE cells at 370C for 30 min led to a marked decrease in this fraction, composed primarily of thymus-derived (T) cells. Supernates of such preincubations were found to cause a reduction in fraction D cells from normal humans. The active factor in the supernate was found to be an IgG antibody. Similarly, serum from patients with active SLE produced a reduction in fraction D cells from normal donors. This activity was also found in the IgG fraction, and could be absorbed with a pure T-cell population.
Depletion of macrophages and complement did not reduce the SLE anti-T-cell antibody-mediated loss of cells from fraction D; however, heat-aggregated human gamma globulin led to impairment of the reaction. These findings suggest that antibody-dependent direct lymphocyte-mediated cytotoxicity may play a role in T-cell lymphopenia of SLE.
It was further noted that the SLE anti-T-cell antibodies, in contrast to rabbit antihuman thymocyte serum, recognized fraction D cells but not fraction E cells from normals. Since both fractions are largely T cells, it appeared that the SLE serum was directed against cellmembrane antigenic determinants present on fraction D T cells, which were absent or reduced in quantity on fraction E T cells. Thus, evidence was presented indiDr. Glinski's present address is the Department of Dermatology, Academy of Medicine, Warsaw, Poland. He performed this work while a Visiting Fellow at the Derma-
INTRODUCTION
In an earlier study, peripheral blood cells from normal humans and patients with systemic lupus were fractionated on discontinuous Ficoll gradients.' Two fractions contained the great majority of thymus-derived (T) cells: fractions D and E. Patients with active systemic lupus erythematosus (SLE)' had a selective reduction in cells from fraction D. Previous observations of antilymphocyte antibodies in patients with active SLE (1) (2) (3) (4) (5) suggested to us that cells from fraction D might be reduced by such antibodies. This was a particularly appealing hypothesis in view of the T-cell specificity of some of these antibodies (6, 7) as well as their ability to alter T-cell functions (8, 9) .
In addition, the relatively greater loss of T cells from fraction D as compared to T cells from fraction E suggested that subpopulations of human T cells might be recognized by SLE anti-T-cell antibodies. The (11, 12) . 3 ml of the Ficoll solutions was carefully layered in sequence, in cellulose nitrate tubes (model 302237, 1 X 3i inches, Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) beginning with the highest density preparation (30%o) at the bottom and ending with 9%o at the top. The cells, suspended in 5% Ficoll, were added as the uppermost layer. The tubes were centrifuged at 10'C for 30 min at 16,000 g (force at bottom of tube) using an SW27 swingingbucket rotor in a model L2-65B ultracentrifuge (Beckman Instruments, Inc., Palo Alto, Calif.). After centrifugation the lymphocytes were distributed at the interfaces. They were removed with Pasteur pipettes and placed into separate 16 X 125-mm plastic test tubes (Falcon Plastics, Oxnard, Calif.) containing 5 ml of HBSS. The fractions were named sequentially from A to G for each interface starting at 9-12%o been depleted of complement activity by heat inactivation and exhaustively absorbed with human tissues including erythrocytes and B cells from a patient with chronic lymphocytic leukemia. It was cytotoxic only for human T cells. It was used in dilutions of 1: 50-1: 600. Typically, 4 X 107 normal PBL (from the Ficoll-Hypaque separation) were suspended in 1 ml of HBSS. The test serum was added and the volume brought to 2 ml with additional HBSS. Thus, addition of 0.25 ml SLE serum would represent a dilution of 1: 8 (025 ml serum in a total volume of 2 ml). Controls consisted of (a) medium only and (b) normal human serum, type AB, which was previously heat inactivated.
The normal lymphocytes at a concentration of 2 X 107/ml were incubated at 370C for 1 h with one of these additional substances and then separated on the discontinuous Ficoll gradient. The total number of cells recovered as well as the number of cells in each fraction was determined for each treatment.
Depletion of macrophages. Macrophages were removed by iron particle phagocytosis. Suspensions of lymphocytes, isolated initially with Ficoll-Hypaque, were mixed 2: 1 (vol: vol) with lymphocyte-separator reagent (Technicon Instruments Corp., Tarrytown, N. Y.) which contains iron particles. After 30 min at 370C, the cells were suspended and the tube placed over a magnet. Iron particles and particlecontaining cells were pulled to the bottom of the tube. The remainder of the cells were aspirated and placed on a Ficoll-Hypaque gradient for reisolation of the lymphocytes, free of remaining iron particles. As a control for this experiment, an aliquot of cells was carried through the same procedures, but without the addition of the lymphocyteseparator reagent.
Complement. To restore complement activity to the medium containing SLE serum, 5% fresh human AB serum was added.
Blocking of cytotoxicity with aggregated human gamma globulin. Human gamma globulin (human Cohn fraction II, E. R. Squibb & Sons, Princeton, N. J.) was dissolved in phosphate-buffered saline (pH 7.2) at a concentration of 10 mg/ml and heated to 63°C for 20 min. The resultant aggregated gamma globulin was diluted to 1 mg/ml, and 0.25 ml was added to 2.0 ml of a suspension of normal lymphocytes (2 X 107/ml). The mixture was incubated at 370C for 15 min after which 0.25 ml of SLE serum was added.
The cells were incubated at 370C for an additional hour and then separated on the discontinuous Ficoll gradient. Control lymphocytes were incubated in the medium (without aggregated gamma globulin) after which 0.25 ml of SLE serum was added and the same procedures carried out. The number of lymphocytes in each fraction and the total number of lymphocytes was determined for both control and aggregated gamma globulin preincubated cells. These were compared to a third aliquot of cells treated with medium only instead of the SLE serum.
Study of IgG and IgM fractions of SLE sera. Serum proteins were precipitated with 50%o saturated ammonium sulfate. The precipitate was centrifuged at 1,000 g for 30 min and dissolved in distilled water. The solution was dialyzed against Tris-buffered saline (pH 7.4) for 48 h and concentrated to 0.5 ml with a collodion bag apparatus (Schleicher and Schuell, Inc., Keene, N. H.-bag 100, lot 79432). The sample was subjected to gel filtration (BioGel A-5m, operating range 10,000-5,000,000 mol wt, BioRad Laboratories, Richmond, Calif. The cells were incubated for 1 h at room temperature and for 24 h at 4VC.
For study of the specificity of anti-T-cell antibodies in ,SLE sera and in ATS, a 1: 5 dilution of SLE serum and a 1: 50 dilution of ATS were absorbed at 220C for 1 h and at 4VC for 24 h with cells of fraction D or fraction E (5 X 108/ml) from a normal individual. (Fig. 1) . The relative percentage of cells forming EAC rosettes rose as the density of Ficoll increased (Fig. 1) . In contrast, fractions B and C were largely (> 80%) composed of cells which did not form E or EAC rosettes (herein called null cells).
RESULTS

Distribution of E and EAC rosette-forming cells in
There were less than 5% macrophages (determined by latex-particle phagocytosis) in any of the fractions, although almost 15% of the initial isolated Ficoll-Hypaque cells were macrophages. This was attributed to the extensive number of washings in plastic tubes and the use of cellulose nitrate ultracentrifuge tubes; these cells appeared to stick to the latter.
Distribution of E and EAC rosette-forming cells in SLE. Patients with inactive SLE resembled normal controls in the relative distribution of E and EAC rosette-forming cells (Fig. 1) . In contrast, patients with active SLE had a reduction in E rosette-forming cells in fractions D, E, and F + G with no change in EAC rosettes ( Fig. 1) continuous Ficoll gradient. Cell counts were performed before and after. No significant changes were observed after incubation at 220C; however, a reduction in total lymphocyte count was observed after the 370C incubation (left-hand part of Fig. 2 ). It was found that the cells were being lost almost entirely from fraction D (center of Fig. 2 ). In 9 of the 10 patients, the reduction in PBL from fraction D was significant and is illustrated in the right-hand part of Fig. 2 Percentage of cells given in parentheses; the total number of cells in medium control taken as 100%. 3). It was noted that the supernate of the 220C incubation of B. A. cells did not alter the normal cell distribution (Fig. 3) . The same results were obtained in 40 experiments using 16 The distribution of normal PBL on the discontinuous Ficoll gradient was altered by SLE serum so as to resemble the distribution of PBL from the serum donor.
However, this was almost completely accounted for by the changes in fraction D, with rather little change in the other fractions (Table II) .
Studies of the mechanism of reduction in lymphocytes in fraction D complement. In the first study, the requirement for the complement was investigated. SLE serum N. M. reduced the number of cells in fraction D of normal PBL. Heating the serum to 560C to inactivate the complement, or adding the complement, did not alter the result (Fig. 4) . These observations, which were repeated three times, suggested that the mechanism of loss of cells from fraction D was not complement mediated.
Macrophages. Normal peripheral blood was depleted of macrophages by the technique of iron-particle phagocytosis and sedimentation in a magnetic field. Depletion
Fractionation of CeUs on a Discontinuous Ficoll Gradient of macrophages had no effect upon the reduction of cells in fraction D by SLE serum in several experiments as illustrated in Fig. 5 . Antibody-dependent direct lymphocyte-mediated cytotoxicity (ADDLC). Numerous experiments indicate that nonsensitized lymphocytes are able to induce cytotoxicity of cells coated with specific antibody (13) (14) (15) (16) (17) (18) . This reaction is inhibited by aggregated gamma globulin (18, 19) . We, therefore, pretreated the normal PBL with aggregated gamma globulin before addition of the SLE serum in an attempt to inhibit ADDLC. Such treatment markedly reduced the loss of cells from fraction D in three separate experiments (Table III) . The serum that most effectively reduced fraction D (B. K.) was still partially active despite the aggregated gamma globulin.
Specificity and antibody nature of the factor in the SLE serum leading to reduction in fraction D. Since fraction D contained primarily T cells, it seemed most likely that the SLE-serum factor responsible for loss of T cells from fraction D was an antibody to T cells. Accordingly, the SLE serum was absorbed with T cells from a patient with the Sezary syndrome, a T-cell malignancy. This absorption eliminated the active factor from three different SLE sera (Table III) , but did not alter normal sera.
The antibody nature of the factor was investigated next. The IgG and IgM fractions of three patients with active SLE and three normals were obtained by gel filtration. The IgM fraction had no effect on the distribution of normal PBL. In contrast, the IgG fraction of each SLE serum was found to be active (Table IV) ; the IgG fractions were as active as the whole sera from the same patients (Table IV) .
Throughout these studies, we were impressed that fraction D, but not fraction E, was recognized by the anti-T-cell antibody in SLE sera. Two possible explanations immediately presented themselves: (a) fraction E cells for some reason were not susceptible to killing or (b) fraction E cells had a reduction in the membrane antigen (s) being recognized by the SLE anti-T-cell antibody. To investigate this further, normal PBL were treated with either an SLE serum or a rabbit antiserum specific for human T cells (ATS). Both sera were first heated to 560C for 1 h to inactivate complement. They 610 To further study differences between fractions D and E, the ATS and SLE sera were first absorbed with fraction D or fraction E from a normal donor. These absorbed sera were then incubated with normal PBL at 370C and the cells fractionated on the discontinuous Ficoll gradient (Table V) . Control unabsorbed SLE serum reduced the cell number in fraction D, but not in fraction E. ATS reduced the number of cells in fraction D and E by approximately the same amount. Absorption of the ATS with either fractions D or E markedly reduced its activity (Table V) . This suggested that this antiserum was able to recognize cell surface-membrane determinants common to both fractions. In contrast, absorption of the SLE serum with the different fractions gave different results. Absorption of the SLE serum with fraction D reduced its activity towards fraction D, whereas absorption with fraction E had no significant effect upon its activity toward fraction D (Table V) . This suggested that the SLE serum recognized surfacemembrane antigeneic determinants of cells in fraction D that were diminished on or absent from fraction E cells.
DISCUSSION
It has been known that patients with active SLE have reduced numbers of total leukocytes (20) (21) (22) and lymphocytes (22) (23) (24) . Furthermore, they have been found to have a reduction in T cells (24, 25) and T-cell functions (26) (27) (28) (29) (30) . Finally, anti-lymphocyte and anti-T cell-antibodies have been found in patients with SLE (1) (2) (3) (4) (5) (6) (7) (8) (9) toxicity, implicating Fc receptor-bearing cells. These observations suggested that ADDLC (10-16) was an important mechanism for T-cell loss in SLE patients, particularly since the reactions were carried out at body temperature, 370C. The possibility of additional mechanisms for T-cell loss was suggested by only partial reduction in activity of an active serum (B. K.) with the aggregated gamma globulin. It was further observed that the SLE anti-T-cell antibodies recognized antigeneic determinants on cells of fraction D that were absent from or much reduced in density on cells of fraction E. Since both fractions contained primarily T cells, it appeared that the SLE antibodies could distinguish among cells in the two fractions leading to loss of cells only from fraction D. This is evidence for two subpopulations of T cells in normal human peripheral blood. The antihuman T-cell antibodies in SLE sera were distinguishable from rabbit antihuman T-cell antibodies. The activity of the former was absorbed to a much greater extent with fraction D than fraction E, providing further evidence for membrane differences between cells in fractions D and E. In contrast, the rabbit antibody activity was equally absorbed with fractions D and E. Thus the rabbit anti-T-cell antibodies recognized all human T cells, whereas the SLE anti-Tcell antibodies recognized preferentially a subpopulation of human T cells.
Since only some of the T cells in fraction D were eliminated by the SLE serum, fraction D itself may contain more than one subpopulation of T cells. Alternatively, soluble immune complexes in SLE sera might have inhibited the ADDLC reaction against antibodycoated fraction D T cells, especially since immune complexes have been shown to inhibit ADDLC (31) and ADDLC is reduced in SLE (32) .
The IgG anti-T-cell antibodies active at 370C which were studied herein appear to be different from the IgM anti-T-cell antibodies which are often more active at low temperatures (2, 4) . The anti-T-cell specificity is analogous to that previously described (6, 7) and may be related to the antibodies which inhibit the mixed-lymphocyte culture (8, 9) . The present studies are also in agreement with a previous observation, suggesting that IgG anti-T-cell antibodies in SLE are only minimally cytotoxic (4). Previous reports of complement-dependent IgG antilymphocyte antibodies in SLE (3, 5) may involve sera with specificities different from those studied in the present report. In fact, the existence of antilymphocyte antibodies with different specificities in SLE sera has recently been emphasized (4).
The effect of supernates from the present study may be related to the "shedding" phenomenon previously described (33) (34) (35) . The IgG nature of the supernatant antibody is in agreement with the elution of IgG antibody from SLE lymphocytes (36) .
Multiple antibodies may be responsible for lymphocyte depletion in SLE. Different mechanisms may be responsible for lymphocyte depletion in SLE. Different mechanisms may be responsible for the loss of different types of cells. Patients with SLE may lose cells from fraction E by a mechanism different from that responsible for the loss of a subpopulation of cells from fraction D. Nevertheless, the observations reported herein suggest that ADDLC is a likely mechanism for loss of at least one 612 W. Glinski New Zealand mice represent animal models of human SLE (37) . These mice spontaneously produce antibodies to T cells (38) , as well as antierythrocyte and antinuclear antibodies. Before the appearance of overt autoimmune disease manifestations, New Zealand mice appear to lose a subpopulation of T cells, which serves a regulatory or suppressor function (39) (40) (41) (42) (43) . It is possible that a similar loss of regulatory T cells occurs in patients with SLE. Investigations of this question are currently in progress.
